OXYGEN RADICAL TOXICITY AND RED CELL PROTEIN DEGRADATION
氧自由基毒性和红细胞蛋白降解
基本信息
- 批准号:3251033
- 负责人:
- 金额:$ 16.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-06-15 至 1993-01-31
- 项目状态:已结题
- 来源:
- 关键词:aminoacid analyzer antioxidants autoradiography blood proteins caseins catalase cell free system complementary DNA electrofocusing enzyme mechanism erythrocytes fluorimetry free radicals gel filtration chromatography glutathione peroxidase hemoglobin high performance liquid chromatography hydrogen peroxide hydroxyl group laboratory rabbit lipid peroxides membrane proteins molecular cloning peptidases protein structure proteolysis radiotracer reticulocytes scintillation counter serum albumin singlet oxygen spectrometry superoxide dismutase superoxides
项目摘要
In recent years it has become increasingly apparent that free
radicals, and related oxidants, play important roles numerous
toxicological processes.
The long-term goal of this research is to understand the mechanisms
of cellular antioxidant protection against environmental and
metabolic toxins.
The objective of this application is to test the following
hypothesis; "Oxygen radicals and other activated oxygen species,
oxidatively denature or fragment hemoglobin, superoxide dismutase,
and other red blood cell proteins. Such modified proteins are
recognized and rapidly degraded by a red cell proteolytic system
which includes a high molecular weight (approximately 700-kDa) ATP-
independent, neutral, endo-protease, and several peptidases. By
preventing the aggregation of denatured proteins, as well as the
potential toxicity of protein fragments, this proteolytic system
acts as a line of "Secondary Antioxidant Defense" for the red cell.
Secondary Antioxidant functions for proteolytic systems in other
cells may be a general biological phenomenon.
The specific aims of this proposal are to quantify and describe
protein damage and degradation in intact erythrocytes and
reticulocytes, the modification of proteins (particularly
hemoglobin and superoxide dismutase) by active oxygen species, the
degradation of modified proteins in cell-free extracts of red blood
cells, and comparative measurements in E. coli. Major specific
aims also include, the purification and characterization of the
red cell 700-kDa protease, production of polyclonal antibodies
against the protease and its subunits, and cloning the protease
subunits in E. coli (using a phage expression vector).
The approaches and methodology include: proteolysis measures with
cell, and purified (labeled) protein modification by
spectrophotometry, fluorometry, scintillation counting, HPLC, LC,
electrophoresis, and IEF; chromatographic isolation of the 700-kDa
protease, generation of antibodies against the protease, and
construction of an affinity column; cloning the protease subunits
in bacteria and construction of a cDNA library (using a lambda gt11
expression vector).
The relationship to health concerns involves: 1) The toxicity of
many "rodox active" xenobiotics (environmental agents and drugs);
2) The defenses of cells against oxidative stresses, in health and
disease; 3) Adaptive responses to toxins and stress.
近年来,越来越明显的是,
自由基和相关的氧化剂在许多方面都起着重要的作用,
毒理学过程
这项研究的长期目标是了解
细胞抗氧化保护,
代谢毒素
本应用程序的目的是测试以下内容
假设;“氧自由基和其他活性氧物质,
氧化变性或片段血红蛋白,超氧化物歧化酶,
和其他红细胞蛋白。 这种修饰的蛋白质是
被红细胞蛋白水解系统识别并迅速降解
其包括高分子量(约700-kDa)ATP-
独立的中性内切蛋白酶和几种肽酶。 通过
防止变性蛋白质的聚集,以及
蛋白质片段的潜在毒性,这种蛋白水解系统
作为红细胞的“二级抗氧化防御”。
其他蛋白水解系统的二级抗氧化功能
细胞可能是一种普遍的生物现象。
本提案的具体目标是量化和描述
完整红细胞中的蛋白质损伤和降解,
网织红细胞,蛋白质的修饰(特别是
血红蛋白和超氧化物歧化酶)的活性氧,
红血无细胞提取物中修饰蛋白质的降解
细胞,并在E.杆菌 主要具体
目的还包括,纯化和表征的
红细胞700-kDa蛋白酶,多克隆抗体的生产
针对蛋白酶及其亚基,并克隆蛋白酶
亚基E. coli(使用噬菌体表达载体)。
方法和方法包括:蛋白水解措施,
细胞和纯化的(标记的)蛋白质修饰,
分光光度法、荧光法、闪烁计数法、HPLC、LC、
电泳和IEF;色谱分离700-kDa
蛋白酶,产生针对蛋白酶的抗体,和
构建亲和柱;克隆蛋白酶亚基
并构建cDNA文库(使用λ> 11
表达载体)。
与健康问题的关系包括:1)
许多具有“氧化还原活性”的外源性物质(环境剂和药物);
2)细胞对氧化应激的防御,在健康和
疾病; 3)对毒素和压力的适应性反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelvin J. A. Davies其他文献
PII: S1567-7249(01)00005-8
PII:S1567-7249(01)00005-8
- DOI:
- 发表时间:
2001 - 期刊:
- 影响因子:0
- 作者:
Daniela A. Bota;Kelvin J. A. Davies - 通讯作者:
Kelvin J. A. Davies
Skin health and biological aging
皮肤健康与生物衰老
- DOI:
10.1038/s43587-025-00901-6 - 发表时间:
2025-06-17 - 期刊:
- 影响因子:19.400
- 作者:
David Furman;Johan Auwerx;Anne-Laure Bulteau;George Church;Virginie Couturaud;Laure Crabbe;Kelvin J. A. Davies;Anabelle Decottignies;Vadim N. Gladyshev;Brian K. Kennedy;Nicola Neretti;Carine Nizard;Karl Pays;Daisy Robinton;Vittorio Sebastiano;Rachel E. B. Watson;Meng C. Wang;Knut Woltjen - 通讯作者:
Knut Woltjen
Kelvin J. A. Davies的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelvin J. A. Davies', 18)}}的其他基金
USC-Buck Geroscience Training Program in the Biology of Aging
南加州大学巴克分校衰老生物学老年科学培训项目
- 批准号:
9074506 - 财政年份:2016
- 资助金额:
$ 16.55万 - 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
- 批准号:
6703655 - 财政年份:2000
- 资助金额:
$ 16.55万 - 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
- 批准号:
6349732 - 财政年份:2000
- 资助金额:
$ 16.55万 - 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
- 批准号:
6071182 - 财政年份:2000
- 资助金额:
$ 16.55万 - 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
- 批准号:
6497189 - 财政年份:2000
- 资助金额:
$ 16.55万 - 项目类别:
ADAPT 78 IN OXIDANT STRESS, AGING AND NEURODEGENERATION
ADAPT 78 对抗氧化应激、衰老和神经退行性变
- 批准号:
6627931 - 财政年份:2000
- 资助金额:
$ 16.55万 - 项目类别:
相似海外基金
Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
- 批准号:
24K18002 - 财政年份:2024
- 资助金额:
$ 16.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
- 批准号:
2222215 - 财政年份:2023
- 资助金额:
$ 16.55万 - 项目类别:
Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
- 批准号:
23K09272 - 财政年份:2023
- 资助金额:
$ 16.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
- 批准号:
10652764 - 财政年份:2023
- 资助金额:
$ 16.55万 - 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
- 批准号:
10730652 - 财政年份:2023
- 资助金额:
$ 16.55万 - 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
- 批准号:
RGPIN-2018-04107 - 财政年份:2022
- 资助金额:
$ 16.55万 - 项目类别:
Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
- 批准号:
22K16720 - 财政年份:2022
- 资助金额:
$ 16.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
- 批准号:
22K11609 - 财政年份:2022
- 资助金额:
$ 16.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
- 批准号:
RGPIN-2019-05674 - 财政年份:2022
- 资助金额:
$ 16.55万 - 项目类别:
Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
- 批准号:
22K12824 - 财政年份:2022
- 资助金额:
$ 16.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




